ASCO in Action

ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.

To sign up for advocacy alerts, log in to with your member or guest account, and visit the subscription center available under your account profile.

Showing results for Coronavirus (COVID-19)

May 9, 2023

On January 30, 2023, the Biden Administration announced the COVID-19 Public Health Emergency (PHE) will end on May 11, 2023. The PHE enabled flexibilities that helped providers treat patients during the pandemic. With the PHE ending, many of these flexibilities are being phased out. The American Society of Clinical Oncology (ASCO) summarized the known end dates of some major flexibilities of interest to oncologists.

April 25, 2023

The Centers for Medicare & Medicaid Services (CMS) will continue to allow clinicians, groups, and virtual groups in the Merit-based Incentive Payment System (MIPS) use the Extreme and Uncontrollable Circumstances exemption application to request reweighting of one or more MIPS performance categories for the 2023 performance year due to the COVID-19 public health emergency (PHE). CMS expects to release the application in spring 2023. MIPS participants wishing to have one or more performance categories reweighted in the 2023 performance year due to the COVID-19 PHE must complete an application.

January 31, 2023

On January 30, 2023, President Biden announced the COVID-19 Public Health Emergency (PHE) will end on May 11, 2023. This announcement comes after the Department of Health and Human Services (HHS) Secretary Xavier Becerra extended the PHE earlier in January.